Levodopa/Carbidopa/Entacapon G.L. Pharma (Entacapone, Levodopa, Carbidopa Monohydrate)

The formulation works on three levels: levodopa is converted to dopamine in the brain, carbidopa blocks peripheral conversion of levodopa so more reaches the central nervous system, and entacapone inhibits the COMT enzyme, slowing levodopa breakdown outside the brain. This synergy provides more stable and prolonged dopaminergic stimulation.

Dosage is individualized and determined by the prescribing clinician based on disease severity, patient response, and tolerability. The prescriber will adjust the amount and frequency to achieve optimal control of Parkinsonian symptoms while minimizing side effects.

Safety data in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.

Standard levodopa/carbidopa provides dopamine replacement but is metabolized quickly, leading to "off" periods. Adding entacapone inhibits COMT, extending levodopa’s half‑life and smoothing out motor fluctuations. This can reduce the number of daily doses needed and improve overall symptom control compared with levodopa/carbidopa alone.

The tablets should be stored at ambient temperature, preferably below 25 °C, in their original container to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Levodopa/Carbidopa/Entacapone is taken orally with a full glass of water. It is usually administered several times a day, with or without food, as directed by the prescriber. Swallow the tablet whole; do not crush or chew unless specifically instructed.

Serious risks include severe hypotension, dyskinesia (involuntary movements), hepatic dysfunction, and rare allergic reactions such as anaphylaxis. Patients should be monitored for sudden drops in blood pressure, abnormal liver tests, and any signs of severe skin rash or breathing difficulty.

The medication is contraindicated in patients with known hypersensitivity to levodopa, carbidopa, entacapone, or any excipients. It should also be avoided in individuals taking non‑selective MAO inhibitors due to the risk of hypertensive crisis, and in patients with severe liver disease without careful medical supervision.